Company Overview
Development, manufacturing and sourcing, distribution and sale of hand and body protection solutions in the industrial and healthcare markets.
Website | www.ansell.com |
---|---|
Head Office | Richmond VIC |
Registry | Computershare Investor Service |
CEO | Neil Salmon |
Chair Person | John Bevan |
GICS Industry | Health Care Equipment & Services |
Sub Industry | Health Care Supplies |
Sector | Health Care |
Market Cap | $3,464 b |
---|---|
Shares on Issue | 127 m |
Status | Trading |
Last Price | |
Change | |
52 Week H/L | |
VWAP | |
Bid/Ask |
Directors and Management
Mr William Peter Day
Non-Executive Director 20/08/2007
Mr Day was formerly Chief Financial Officer of Amcor Limited for seven years, and Chief Financial Officer and Executive Director Finance of Bonlac Foods Limited. He also has held senior office and executive positions in the Australian Securities and Investments Commission (Deputy Chair), Rio Tinto, CRA and Comalco. He is also involved with disability services and disability services and education initiatives. He has a background in finance and general management across diverse and international industries. Mr Day is Member of the Sustainability and Risk Committee and member of the Governance Committee. He is Chairman of Alumina Limited , and Chairman of Australian Unity Investment Real Estate Limited and Former Director of Boart Longyear Limited, SAI Global Limited, Orbital Corporation Limited, Centro Retail and Federation Centres.
LLB (Hons), MBA, FCA , FCPA , FTIA , FAICD Male
Mr Nigel David Garrard
Non-Executive Director 01/03/2020
Mr Garrard is an experienced executive with a track record across FMCG and Industrial/Manufacturing sectors. Mr Garrard has 20 year's experience as an ASX-listed CEO across three companies. In 2019, Mr Garrard retired as Managing Director and CEO of Orora Limited. Mr Garrard led the demerger of Orora from Amcor, and subsequent listing on the ASX in 2013. Mr Garrard was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatil's Food and Services Division and Managing Director of SPC Ardmona. Mr Garrard brings international experience across listed, not-for-profit, government and private entities. He is the Member of the Human Resources Committee (Chair from 1 July 2021) and member of the Sustainability and Risk Committee. He is Chairman of McMahon Services, Non-Executive Director of Hudson Institute of Medical Research and CSR Ltd . Previous Directorships include Managing Director of Orora Limited, Managing Director of Amcor Australasia and Packaging Distribution , Managing Director of SPC Ardmona Limited , Managing Director of Chiquita Brands South Pacific Ltd.
BEco, CA, MAICD Male
Mr William G Reilly
Non-Executive Director 20/10/2017
Mr Reilly has over 35 years experience as an in-house lawyer. Mr Reilly was appointed as General Counsel of Ansell Healthcare in 2000 when it was a division of Pacific Dunlop Limited, subsequently becoming General Counsel of Ansell Limited in 2002. Mr Reilly has served with three Chief Executive Officers and has played pivotal roles leading many of Ansell's corporate strategic and legal initiatives, including M&A, litigation and the successful intellectual property strategy. He has also overseen the Global Compliance and Risk functions, acted as interim head of Human Resources, leader of the Regulatory function and joint Company Secretary. Prior to joining Ansell, Mr Reilly held senior legal positions at C. R. Bard, Inc., The Hertz Corporation and McKesson Corporation. In 2016, Mr Reilly was named on the Financial Times first ever Global GC 30 List. Mr Reilly is Member of the Sustainability and Risk Committee, the Human Resources Committee and the Governance Committee.
BA, J.D. Male
Ms Marissa T Peterson
Non-Executive Director 22/08/2006
Mrs Peterson currently runs Mission Peak Executive Consulting, an executive coaching and consulting firm specialising in helping develop, grow and scale leaders in the high technology space. Mrs Peterson retired from full-time executive roles in 2006, having spent 18 years with Sun Microsystems with an unprecedented legacy of concurrently leading some of Sun's largest and most effective organisations: as Executive Vice President of Services, Executive Vice President of Worldwide Operations, and as Chief Customer Advocate. She has extensive experience in supply chain management, manufacturing and quality, logistics, information technologies, customer advocacy and leadership development. Mrs Peterson Member of the Human Resources Committee.
She is Director of Humana Inc and a Former Chair of Oclaro Inc.
BSc (Mech), MBA , Hon Doctorate (MGMT) Female
Mr John Andrew Bevan
Non-Executive Director,Non-Executive Chairman 01/08/2012
Mr Bevan was formerly the Chief Executive Officer and Executive Director of Alumina Limited and brings to the Board international business experience. Prior to joining Alumina Limited, he had a career with the BOC Group Plc, where he was a member of the Board of Directors and held a variety of senior management positions in Australia, Korea, Thailand, Singapore and the UK. He is Chair of the Governance Committee and member of the Human Resources Committee. He is Chairman of BlueScope Steel Limited, Non-Executive Director of Humpty Dumpty Foundation and Alumina Limited and Former Director of Non-Executive Director of Nuplex Industries Limited, Executive Director of Alumina Limited.
BCom (Mkt), FAICD Male
Ms Leslie A Desjardins
Non-Executive Director 30/11/2015
Mrs Desjardins is a former international finance executive with experience in business performance and growth. Mrs Desjardins was formerly the Chief Financial Officer of Amcor Limited. Prior to Amcor, she held executive roles at General Motors Corporation, in Canada, the US and Australia, including Chief Financial Officer GM Holden, Controller for GM North America, and Finance Director for GM's manufacturing facilities in North America. Mrs Desjardins has experience in finance, M&A, strategy, government relations and global operations. She is member of the Sustainability and Risk Committee. She is the Non-Executive Director and Audit and Risk Committee Chair of ALS Limited, Non-Executive Director and Audit Committee Chair of Terry Fox Cancer Foundation and Former Director of Aptar Group.
B(IndusAdmin,Fin),MSc(Mgmt) Female
Mrs Christina Stercken
Non-Executive Director 20/10/2017
Mrs Stercken was a partner at Euro Asia Consulting PartG (EAC) until the end of 2017. In this function, Mrs Stercken helped customers in machinery, automotive, chemical, healthcare and infrastructure industries in strategy, M&A and operational excellence in growth markets. Before joining EAC, Mrs Stercken served as Managing Director Corporate Finance M&A of Siemens AG. Among other management positions within Siemens AG, she was responsible for the Siemens Task Force China and Head of Public Sector Business Unit at Siemens Business Services. Mrs Stercken started her career in Marketing at BMW Pty. Ltd, South Africa. Mrs Stercken brings a range of competencies relevant to Ansell's strategies, including M&A, broad industry background and business building in developing markets. In her function as Vice Chairman of Myanmar Foundation, Munich, Mrs Stercken supports social Stercken supports social projects in Myanmar. She is the Member of the Sustainability and Risk Committee.She is director of Landis & Gyr Group AG , Myanmar Foundation (Vice Chairman and Former Director of Ascom Holding AG.
BEco,BBA,MEco,ExeMBA, Female
Ms Christine Yingli Yan
Non-Executive Director 20/02/2019
Ms Yan is an experienced executive who has had a career at Stanley Black & Decker. Ms Yan has held senior management positions in both the US and China, including Vice President of Sales and Marketing for North America Automotive, President of the Global Automotive Division, President of Americas for the Engineered Fastening division, President of Stanley Storage and Workspace Systems and more recently, President of Asia and Vice President of Integration. Ms Yan brings a range of general management experience across different geographies, as well as experience in innovation, business development, sales, digital transformation and marketing in the businessto- business industry. She is the Member of the Human Resources Committee. She is currently Non-Executive Director of ON Semiconductor Corporation, Non- Executive Director of Modine Manufacturing Company Inc. and Non-Executive Director of Cabot Corporation.
BMech Eng, MMech Eng, MBA Female
Mr Neil Salmon
Chief Executive Officer,Managing Director 01/09/2021
Mr Salmon is currently President of the Industrial Global Business Unit, having served as Chief Financial officer for 6 years. Neil has more than 20 years of experience, gained working across a range of roles in a group of international businesses. He spent the first 17 years of his career with Imperial Chemical Industries (ICI) primarily in finance roles based in the UK, South Africa, the US and Singapore. After ICI he served as Chief Financial Officer of Innophos in New Jersey, prior to joining Ansell.
BA(Politics, Philosophy & Eco),CMA(ACMA, CGMA) Male
Top 20 Shareholders
Name | Shares | % | |
---|---|---|---|
1. | HSBC Custody Nominees (Australia) Limited | 46,082,341 | 36.00 |
2. | J P Morgan Nominees Australia Pty Limited | 19,774,760 | 15.45 |
3. | Citicorp Nominees Pty Limited | 12,892,489 | 10.07 |
4. | National Nominees Limited | 6,829,707 | 5.34 |
5. | HSBC Custody Nominees (Australia) Limited (I) | 2,117,496 | 1.65 |
6. | BNP Paribas Noms Pty Ltd (DRP) | 1,665,259 | 1.30 |
7. | BNP Paribas Nominees Pty Ltd (Agency Lending DRP A/C) | 1,490,115 | 1.16 |
8. | Australian Foundation Investment Company Limited | 1,078,865 | 0.84 |
9. | Netwealth Investments Limited (Wrap Services A/C) | 763,076 | 0.60 |
10. | CPU Share Plans Pty Ltd (PSR Nor Unallocated A/C) | 700,000 | 0.55 |
11. | National Nominees Limited (DB A/C) | 668,908 | 0.52 |
12. | BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd (DRP A/C) | 611,184 | 0.48 |
13. | HSBC Custody Nominees (Australia) Limited A/C 2 | 409,607 | 0.32 |
14. | BNP Paribas Nominees Pty Ltd Six Sis Ltd (DRP A/C) | 389,719 | 0.30 |
15. | Citicorp Nominees Pty Limited (Colonial First State Inv A/C) | 383,789 | 0.30 |
16. | Australian Executor Trustees Limited (No 1 Account) | 304,745 | 0.24 |
17. | AMP Life Limited | 285,423 | 0.22 |
18. | Mirrabooka Investments Limited | 273,499 | 0.21 |
19. | BNP Paribas Noms (NZ) Ltd (DRP) | 259,347 | 0.20 |
20. | Australian Executor Trustees Limited (IPS Super A/C) | 243,535 | 0.19 |
Director Transactions
Date | Name | Qty | Value | Direction | Notes |
---|---|---|---|---|---|
30/09/2021 | John Bevan | 97 | $3,311 | Buy | Participation in share purchase plan. |
30/09/2021 | Christina Stercken | 147 | $5,018 | Buy | Participation in share purchase plan. |
30/09/2021 | Christine Yan | 159 | $5,428 | Buy | Participation in share purchase plan. |
31/08/2021 | Christine Yan | 165 | $5,925 | Buy | Participation in share purchase plan. |
31/08/2021 | Christina Stercken | 152 | $5,458 | Buy | Participation in share purchase plan. |
31/08/2021 | John Bevan | 92 | $3,303 | Buy | Participation in share purchase plan. |
31/08/2021 | Magnus Nicolin | 184,505 | $6,675,970 | Exercise | Conversion of securities. 184,621 - performance share rights As per announcement on 02/09/2021 |
31/08/2021 | Magnus Nicolin | 184,505 | $6,675,970 | Buy | Conversion of securities. |
31/08/2021 | Magnus Nicolin | 70,787 | $2,553,558 | Sell | On-market trade. |
27/08/2021 | Nigel Garrard | 1,000 | $36,375 | Buy | On-market trade. |
26/08/2021 | John Bevan | 90 | $3,289 | Buy | Participation in share purchase plan. |
26/08/2021 | Christina Stercken | 124 | $4,532 | Buy | Participation in share purchase plan. |
26/08/2021 | Christine Yan | 133 | $4,861 | Buy | Participation in share purchase plan. |
30/06/2021 | Christine Yan | 104 | $4,567 | Buy | Participation in share purchase plan. |
30/06/2021 | Christina Stercken | 70 | $3,074 | Buy | Participation in share purchase plan. |
30/06/2021 | John Bevan | 144 | $6,324 | Buy | Participation in share purchase plan. |
30/06/2021 | Leslie Desjardins | 78 | $3,425 | Buy | Participation in share purchase plan. |
31/05/2021 | Leslie Desjardins | 83 | $3,426 | Buy | Participation in share purchase plan. |
31/05/2021 | John Bevan | 153 | $6,316 | Buy | Participation in share purchase plan. |
31/05/2021 | Christina Stercken | 73 | $3,013 | Buy | Participation in share purchase plan. |
31/05/2021 | Christine Yan | 110 | $4,541 | Buy | Participation in share purchase plan. |
30/04/2021 | Christine Yan | 110 | $4,648 | Buy | Participation in share purchase plan. |
30/04/2021 | Christina Stercken | 74 | $3,127 | Buy | Participation in share purchase plan. |
30/04/2021 | John Bevan | 152 | $6,423 | Buy | Participation in share purchase plan. |
30/04/2021 | Leslie Desjardins | 83 | $3,507 | Buy | Participation in share purchase plan. |
31/03/2021 | Leslie Desjardins | 86 | $3,409 | Buy | Participation in share purchase plan. |
31/03/2021 | John Bevan | 159 | $6,304 | Buy | Participation in share purchase plan. |
31/03/2021 | Christina Stercken | 76 | $3,013 | Buy | Participation in share purchase plan. |
31/03/2021 | Christine Yan | 114 | $4,520 | Buy | Participation in share purchase plan. |
19/03/2021 | Christina Stercken | 800 | $29,600 | Buy | On-market trade. |
26/02/2021 | Christina Stercken | 86 | $3,108 | Buy | Participation in share purchase plan. |
26/02/2021 | Christine Yan | 129 | $4,662 | Buy | Participation in share purchase plan. |
26/02/2021 | John Bevan | 178 | $6,432 | Buy | Participation in share purchase plan. |
26/02/2021 | Leslie Desjardins | 97 | $3,505 | Buy | Participation in share purchase plan. |
18/02/2021 | Leslie Desjardins | 84 | $3,373 | Buy | Participation in share purchase plan. |
18/02/2021 | John Bevan | 157 | $6,305 | Buy | Participation in share purchase plan. |
18/02/2021 | Christine Yan | 113 | $4,538 | Buy | Participation in share purchase plan. |
18/02/2021 | Christina Stercken | 75 | $3,012 | Buy | Participation in share purchase plan. |
21/01/2021 | Magnus Nicolin | 80,000 | $2,923,200 | Transfer | As advised by the company. 80,000 ordinary shares transferred from Mr. Nicolin's "direct" shareholding to his "indirect" shareholding (held by Skandinaviska Enskilda Banken on behalf of Magnus R Nicolin and Sofie Nicolin) |
21/01/2021 | Magnus Nicolin | 80,000 | $2,923,200 | Transfer | As advised by the company. 80,000 ordinary shares transferred from Mr. Nicolin's "direct" shareholding to his "indirect" shareholding (held by Skandinaviska Enskilda Banken on behalf of Magnus R Nicolin and Sofie Nicolin) As per announcement on 27/01/2021. |
31/12/2020 | Leslie Desjardins | 103 | $3,617 | Buy | Participation in share purchase plan. |
31/12/2020 | John Bevan | 188 | $6,602 | Buy | Participation in share purchase plan. |
31/12/2020 | Christina Stercken | 90 | $3,160 | Buy | Participation in share purchase plan. |
31/12/2020 | Christine Yan | 136 | $4,776 | Buy | Participation in share purchase plan. |
30/12/2020 | Magnus Nicolin | 80,677 | $2,843,864 | Issued | Issue of securities. 286,165 - performance share rights |
08/12/2020 | William Reilly | 7,500 | $260,025 | Sell | On-market trade. |
30/11/2020 | John Bevan | 182 | $6,825 | Buy | Participation in share purchase plan. |
30/11/2020 | Leslie Desjardins | 98 | $3,675 | Buy | Participation in share purchase plan. |
30/11/2020 | Christina Stercken | 88 | $3,300 | Buy | Participation in share purchase plan. |
30/11/2020 | Christine Yan | 132 | $4,950 | Buy | Participation in share purchase plan. |
24/11/2020 | Nigel Garrard | 650 | $24,180 | Buy | On-market trade. |
12/11/2020 | Magnus Nicolin | 80,000 | $3,178,949 | Sell | On-market trade. |
30/10/2020 | John Bevan | 168 | $6,871 | Buy | Participation in share purchase plan. |
30/10/2020 | Christina Stercken | 81 | $3,312 | Buy | Participation in share purchase plan. |
30/10/2020 | Leslie Desjardins | 91 | $3,721 | Buy | Participation in share purchase plan. |
30/10/2020 | Christine Yan | 121 | $4,948 | Buy | Participation in share purchase plan. |